Nanotechnology Drug Delivery Market

Nanotechnology Drug Delivery Market (Technology: Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others; and Application: Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Nanotechnology Drug Delivery Market Outlook 2028

  • The global nanotechnology drug delivery market was valued at US$ 77.1 Bn in 2020
  • It is estimated to expand at a CAGR of 7.9% from 2021 to 2028
  • The global nanotechnology drug delivery market is expected to cross the value of US$ 142.8 Bn by the end of 2028

Analysts’ Viewpoint on Nanotechnology Drug Delivery Market Scenario

The global nanotechnology drug delivery market is expected to witness tremendous growth opportunities due to rising incidences of oncology and chronic disorders across the globe. Companies in the global nanotechnology drug delivery market are gaining lucrative revenue opportunities due to a large number of ongoing clinical trials, outsourcing services, research activities, and increase in healthcare investment by governments. However, high cost of medicines and stringent regulations associated with nanotechnology drug delivery are some of the factors expected to impact the growth of the global nanotechnology drug delivery market during the forecast period.

Rise in Awareness of Nanotechnology Drug Delivery System

The nanotechnology drug delivery market is significantly driven by factors such as increasing awareness among the people about nanotechnology, rapidly increasing incidences of chronic illnesses, technological advancement, and rising investment in nanotechnology by government in several developing countries. Due to rising demand for novel drug delivery, manufacturers are gaining lucrative growth opportunities in the global market. Nanotechnology drug delivery is an expanding area of the healthcare industry, and is witnessing increasing acceptance in medical and healthcare applications.

The nanotechnology drug delivery system is used in neurology, anti-infective, cardiovascular disorders, and others. The system also has an application in transporting drugs to the final location of therapeutic intervention within the body. The nanotechnology drug delivery market is witnessing rapid growth due to increase in R&D activities in nanotechnology to develop novel nano-medicine. Various organic and inorganic nanomaterials have been utilized for DDS applications. The term nano pharmaceuticals cover different nano-based DDS that can be used to encapsulate drugs for better targeting than with conventional drugs.

To know the scope of our report Get a Sample on Nanotechnology Drug Delivery Market

Expanding Pharmaceutical Drug Development Companies Globally

There is a flourishing growth of pharmaceutical companies across the globe. Rising investment in R&D activities in drug development and discovery is contributing to expansion of the nanotechnology drug delivery market. The global pharmaceutical industry has been developing compounds for over a century. Many of these never reached the market. The acceptance of new drug formulations is expensive and slow process. It takes so many years to obtain accreditation of new drug formulas with no guarantee of success. Antineoplastic agents are highly effective in cancer treatment. However, it leads to chronic side effects due to cytotoxic properties and lack of target specificity. Hence, pharmaceutical companies are developing innovative drug delivery systems in order to increase target specificity for the cytotoxic drugs that are already present in the market.

Get a glimpse of the in-depth analysis through our Report Brochure

Clinical Advantages of Nanotechnology in Drug Delivery

The global nanotechnology drug delivery market has been classified into nanocrystals, liposomes, micelles, nanoparticles, nanotubes, etc. There has been a major role of a technology in the delivery of medicine to measure the size of the particles in nanometer ranges. The rising acceptance of nanotechnology-based drug delivery systems for both doctors and patients is due to lower drug toxicity, more specific targeting, and reduced cost of treatment. Nowadays, several drug entities fail clinical trials, as the compound is incapable to reach the targeted site without exhibiting any side effects. The delivery of a compound to specific target site is the most important part of any treatment ranging from infections to cancer. The overall drug consumption and side effects can be reduced with the help of the nanotechnology drug delivery system.

The nanotechnology drug delivery system is used in the field of neurology, oncology, cardiovascular/physiology, anti-inflammatory/immunology, anti-infective, and others. Oncology is the largest segment of the global market and expected to witness lucrative growth potential in the upcoming years due to rising cancer cases across the globe.

Expanding operations in future? To get the perfect launch ask for a custom report

Booming North America Nanotechnology Drug Delivery Market

North America is expected to account for a major market share of the global nanotechnology drug delivery market. Some of the key factors responsible for the market growth are well-established healthcare infrastructure and increase in number of biopharmaceutical companies in the region. The increasing prevalence chronic diseases all over the world demand technologically advanced drug delivery systems. Asia Pacific and Latin America are other attractive markets, which are poised to rise due to the increasing healthcare spending and improving healthcare facilities. This is due to economic growth, rise in spending capacity, surge in prevalence of cancers, and improvement in healthcare infrastructure.

Nanotechnology Drug Delivery Market: Overview

  • The role of technology in the delivery of medicine assures revolutionary advances in measuring the size of the particles in nanometer ranges
  • One important and active application area of nanotechnology drug delivery systems (DDS) is to transport drugs to the final location of therapeutic intervention within the body. Various organic and inorganic nanomaterials have been utilized for DDS applications.
  • The term nano pharmaceuticals (nano drugs) cover different nano-based DDS that can be used to encapsulate drugs for better targeting than with conventional drugs
  • The most common nanomaterials utilized for DDS include nanocrystals, liposome, protein-conjugate, dendrimers, and nanoparticles

Developing Potential of Existing Pharmaceutical Drugs: Key Driver

  • The global pharmaceutical industry has been developing compounds for over a century. However, several of these never got to the market. Acceptance of new drug formulations is expensive and slow, taking up to 15 years to obtain accreditation of new drug formulas with no guarantee of success.
  • Antineoplastic agents are highly effective in cancer treatment; however, it leads to chronic side effects due to cytotoxic properties and lack of target specificity. Hence, pharmaceutical companies are developing innovative drug delivery systems to increase target specificity for the cytotoxic drugs that are already present in the market.
  • New drug delivery compounds are likely to extend the product and patent lifecycles of drugs, enabling the creation of new chemical entities (NCEs) via reformulation of existing and/or orphaned compounds, and subsequent creation of value for shareholders and consumers
  • Therefore, renewing the product lifecycle of existing drugs is expected to boost market growth during the forecast period

Clinical Advantages of Nanotechnology in Drug Delivery: Major Driver

  • Benefits of nanotechnology-based drug delivery systems for both doctors and patients are lower drug toxicity, more specific targeting, and reduced cost of treatment
  • Presently, several drug entities fail clinical trials because the compound is incapable to reach the targeted site without exhibiting any side effects. Delivery of a compound to specific target site is one of the most integral parts of any treatment ranging from infections to cancer.
  • The overall drug consumption and side effects can be lowered significantly using nanotechnology drug delivery. The highly selective approach reduces the side effects and cost as well.
  • These factors are likely to propel the global nanotechnology drug delivery market during the forecast period

Nanotechnology Drug Delivery Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 77.1 Bn

Market Forecast Value in 2028

US$ 142.8 Bn

Growth Rate (CAGR)

7.9 %

Forecast Period

2017–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Technology
    • Nanocrystals
    • Nanoparticles
      • Dendrimers
      • Gold Nanoparticles
      • Fullerenes
    • Liposomes
    • Micelles
    • Nanotubes
    • Others
  • Application
    • Neurology
    • Oncology
    • Cardiovascular/Physiology
    • Anti-inflammatory/Immunology
    • Anti-infective
    • Others (Hematology, Ophthalmology, etc.)

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Customization Scope

Available upon request

Pricing

Available upon request

Nanotechnology Drug Delivery Market – Segmentation

TMR’s study on the global nanotechnology drug delivery market includes information divided into three segments: technology, application, and region. Changing industry trends and other market dynamics associated with these segments of the global nanotechnology drug delivery market are discussed in detail.

Technology
  • Nanocrystals
  • Nanoparticles
    • Dendrimers
    • Gold Nanoparticles
    • Fullerenes
  • Liposomes
  • Micelles
  • Nanotubes
  • Others
Application
  • Neurology
  • Oncology
  • Cardiovascular / Physiology
  • Anti-Inflammatory / Immunology
  • Anti-Infective
  • Others (Hematology, Ophthalmology, etc.)
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of nanotechnology drug delivery market?

Nanotechnology drug delivery market is expected to cross the value of US$ 142.8 Bn by the end of 2028

What would be the CAGR of the nanotechnology drug delivery market during the forecast period?

Nanotechnology drug delivery market is estimated to expand at a CAGR of 7.9% from 2021 to 2028

What are the key factors driving the nanotechnology drug delivery market?

The nanotechnology drug delivery market is driven increasing awareness among the people about nanotechnology and rapidly increasing incidences of chronic illnesses

Which region is more attractive for vendors in the nanotechnology drug delivery market?

North America is more attractive for vendors in the nanotechnology drug delivery market

Who are the key players in the nanotechnology drug delivery market?

Key players in the global nanotechnology drug delivery market include AbbVie, Inc., Amgen, Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Nanotechnology Drug Delivery Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Technology Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Nanotechnology Drug Delivery Market Analysis and Forecast, 2017–2028

            4.4.1. Market Revenue Projections (US$ Mn)

            4.4.2. Market Volume/Unit Shipments Projections

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Technological Advancements

        5.2. Pricing Analysis

        5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)

        5.4. Covid-19 Impact Analysis

    6. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Technology

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value & Volume Forecast, by Technology, 2017–2028

            6.3.1. Nanocrystals

            6.3.2. Nanoparticles

                6.3.2.1. Dendrimers

                6.3.2.2. Gold Nanoparticles

                6.3.2.3. Fullerenes

                6.3.2.4. Others

            6.3.3. Liposomes

            6.3.4. Micelles

            6.3.5. Nanotubes

            6.3.6. Others

        6.4. Market Attractiveness Analysis, by Technology

    7. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value & Volume Forecast, by Application, 2017–2028

            7.3.1. Neurology

            7.3.2. Oncology

            7.3.3. Cardiovascular/Physiology

            7.3.4. Anti-inflammatory/Immunology

            7.3.5. Anti-infective

            7.3.6. Others (hematology, ophthalmology, etc.)

        7.4. Market Attractiveness Analysis, by Application

    8. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value & Volume Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Country/Region

    9. North America Nanotechnology Drug Delivery Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value & Volume Forecast, by Technology, 2017–2028

            9.2.1. Nanocrystals

            9.2.2. Nanoparticles

                9.2.2.1. Dendrimers

                9.2.2.2. Gold Nanoparticles

                9.2.2.3. Fullerenes

                9.2.2.4. Others

            9.2.3. Liposomes

            9.2.4. Micelles

            9.2.5. Nanotubes

            9.2.6. Others

        9.3. Market Value & Volume Forecast, by Application, 2017–2028

            9.3.1. Neurology

            9.3.2. Oncology

            9.3.3. Cardiovascular/Physiology

            9.3.4. Anti-inflammatory/Immunology

            9.3.5. Anti-infective

            9.3.6. Others (hematology, ophthalmology, etc.)

        9.4. Market Value & Volume Forecast, by Country, 2017–2028

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Technology

            9.5.2. By Application

            9.5.3. By Country

    10. Europe Nanotechnology Drug Delivery Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value & Volume Forecast, by Technology, 2017–2028

            10.2.1. Nanocrystals

            10.2.2. Nanoparticles

                10.2.2.1. Dendrimers

                10.2.2.2. Gold Nanoparticles

                10.2.2.3. Fullerenes

                10.2.2.4. Others

            10.2.3. Liposomes

            10.2.4. Micelles

            10.2.5. Nanotubes

            10.2.6. Others

        10.3. Market Value & Volume Forecast, by Application, 2017–2028

            10.3.1. Neurology

            10.3.2. Oncology

            10.3.3. Cardiovascular/Physiology

            10.3.4. Anti-inflammatory/Immunology

            10.3.5. Anti-infective

            10.3.6. Others (hematology, ophthalmology, etc.)

        10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Technology

            10.5.2. By Application

            10.5.3. By Country/Sub-region

    11. Asia Pacific Nanotechnology Drug Delivery Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value & Volume Forecast, by Technology, 2017–2028

            11.2.1. Nanocrystals

            11.2.2. Nanoparticles

                11.2.2.1. Dendrimers

                11.2.2.2. Gold Nanoparticles

                11.2.2.3. Fullerenes

                11.2.2.4. Others

            11.2.3. Liposomes

            11.2.4. Micelles

            11.2.5. Nanotubes

            11.2.6. Others

        11.3. Market Value & Volume Forecast, by Application, 2017–2028

            11.3.1. Neurology

            11.3.2. Oncology

            11.3.3. Cardiovascular/Physiology

            11.3.4. Anti-inflammatory/Immunology

            11.3.5. Anti-infective

            11.3.6. Others (hematology, ophthalmology, etc.)

        11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Technology

            11.5.2. By Application

            11.5.3. By Country/Sub-region

    12. Latin America Nanotechnology Drug Delivery Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value & Volume Forecast, by Technology, 2017–2028

            12.2.1. Nanocrystals

            12.2.2. Nanoparticles

                12.2.2.1. Dendrimers

                12.2.2.2. Gold Nanoparticles

                12.2.2.3. Fullerenes

                12.2.2.4. Others

            12.2.3. Liposomes

            12.2.4. Micelles

            12.2.5. Nanotubes

            12.2.6. Others

        12.3. Market Value & Volume Forecast, by Application, 2017–2028

            12.3.1. Neurology

            12.3.2. Oncology

            12.3.3. Cardiovascular/Physiology

            12.3.4. Anti-inflammatory/Immunology

            12.3.5. Anti-infective

            12.3.6. Others (hematology, ophthalmology, etc.)

        12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Technology

            12.5.2. By Application

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Nanotechnology Drug Delivery Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value & Volume Forecast, by Technology, 2017–2028

            13.2.1. Nanocrystals

            13.2.2. Nanoparticles

                13.2.2.1. Dendrimers

                13.2.2.2. Gold Nanoparticles

                13.2.2.3. Fullerenes

                13.2.2.4. Others

            13.2.3. Liposomes

            13.2.4. Micelles

            13.2.5. Nanotubes

            13.2.6. Others

        13.3. Market Value & Volume Forecast, by Application, 2017–2028

            13.3.1. Neurology

            13.3.2. Oncology

            13.3.3. Cardiovascular/Physiology

            13.3.4. Anti-inflammatory/Immunology

            13.3.5. Anti-infective

            13.3.6. Others (hematology, ophthalmology, etc.)

        13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Technology

            13.5.2. By Application

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player – Competition Matrix (by tier and size of companies)

        14.2. Market Share Analysis, by Company, 2020

        14.3. Market Footprint Analysis

            14.3.1. By Region

            14.3.2. By Technology

            14.3.3. By Application

        14.4. Competitive Business Strategies

        14.5. Company Profiles

            14.5.1. AbbVie, Inc.

                14.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.5.1.2. Product Portfolio

                14.5.1.3. SWOT Analysis

                14.5.1.4. Strategic Overview

            14.5.2. Amgen, Inc.

                14.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.5.2.2. Product Portfolio

                14.5.2.3. SWOT Analysis

                14.5.2.4. Strategic Overview

            14.5.3. Celgene Corporation

                14.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.5.3.2. Product Portfolio

                14.5.3.3. SWOT Analysis

                14.5.3.4. Strategic Overview

            14.5.4. Johnson & Johnson

                14.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.5.4.2. Product Portfolio

                14.5.4.3. SWOT Analysis

                14.5.4.4. Strategic Overview

            14.5.5. Merck & Co., Inc.

                14.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.5.5.2. Product Portfolio

                14.5.5.3. SWOT Analysis

                14.5.5.4. Strategic Overview

            14.5.6. Perrigo Company plc

                14.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.5.6.2. Product Portfolio

                14.5.6.3. SWOT Analysis

                14.5.6.4. Strategic Overview

            14.5.7. Pfizer, Inc.

                14.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.5.7.2. Product Portfolio

                14.5.7.3. SWOT Analysis

                14.5.7.4. Strategic Overview

            14.5.8. Teva Pharmaceutical Industries Ltd.

                14.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.5.8.2. Product Portfolio

                14.5.8.3. SWOT Analysis

                14.5.8.4. Strategic Overview

            14.5.9. Other players

    List of Table

    Table 01: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028

    Table 02: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

    Table 03: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Region, 2021–2028

    Table 04: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028

    Table 05: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country, 2021–2028

    Table 06: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

    Table 07: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028

    Table 08: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

    Table 09: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2021–2028

    Table 10: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028

    Table 11: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

    Table 12: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2021–2028

    Table 13: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2017–2028

    Table 14: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

    Table 15: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2017–2028

    Table 16: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2017–2028

    Table 17: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

    Table 18: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2017–2028

    List of Figures

    Figure 01: Global Nanotechnology Drug Delivery Market Snapshot

    Figure 02: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2017–2028

    Figure 03: Market Value Share, by Technology, 2020

    Figure 04: Market Value Share, by Application, 2020

    Figure 05: Market Value Share, by Region, 2020

    Figure 06: Global Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

    Figure 07: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Nanocrystals, 2017–2028 

    Figure 08: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Nanoparticles, 2017–2028

    Figure 09: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Liposomes, 2017–2028

    Figure 10: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Micelles, 2017–2028

    Figure 11: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Nanotubes, 2017–2028

    Figure 12: Global Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

    Figure 13: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Neurology, 2017–2028 

    Figure 14: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Oncology, 2017–2028

    Figure 15: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Cardiovascular/Physiology, 2017–2028

    Figure 16: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Anti-inflammatory/Immunology, 2017–2028

    Figure 17: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Anti-infective, 2017–2028

    Figure 18: Global Nanotechnology Drug Delivery Market Value Share Analysis, by Region, 2020 and 2028

    Figure 19: Global Nanotechnology Drug Delivery Market Attractiveness Analysis, by Region

    Figure 20: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, 2021–2028

    Figure 21: North America Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country, 2020 and 2018

    Figure 22: North America Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

    Figure 23: North America Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

    Figure 24: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, 2021–2028

    Figure 25: Europe Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region

    Figure 26: Europe Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

    Figure 27: Europe Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

    Figure 28: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017– 2027

    Figure 29: Asia Pacific Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

    Figure 30: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

    Figure 31: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

    Figure 32: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

    Figure 33: Latin America Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

    Figure 34: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

    Figure 35: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

    Figure 36: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, 2017–2028

    Figure 37: Middle East & Africa Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region

    Figure 38: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

    Figure 39: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

    Figure 40: Global Nanotechnology Drug Delivery Market Share Analysis, by Company (2020)

Copyright © Transparency Market Research, Inc. All Rights reserved